GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Bioqual Inc (OTCPK:BIOQ) » Definitions » EPS (Diluted)

Bioqual (Bioqual) EPS (Diluted) : $4.10 (TTM As of May. 2018)


View and export this data going back to . Start your Free Trial

What is Bioqual EPS (Diluted)?

Bioqual's Earnings per Share (Diluted) for the six months ended in May. 2018 was $4.10. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in May. 2018 was $4.10.

Bioqual's EPS (Basic) for the six months ended in May. 2018 was $4.10. Its EPS (Basic) for the trailing twelve months (TTM) ended in May. 2018 was $4.10.

Bioqual's EPS without NRI for the six months ended in May. 2018 was $4.09. Its EPS without NRI for the trailing twelve months (TTM) ended in May. 2018 was $4.09.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.


Bioqual EPS (Diluted) Historical Data

The historical data trend for Bioqual's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioqual EPS (Diluted) Chart

Bioqual Annual Data
Trend May01 May03 May04 May05 May06 May07 May10 May11 May17 May18
EPS (Diluted)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.19 0.46 0.45 4.44 4.10

Bioqual Semi-Annual Data
May96 May97 May98 May99 May00 May01 May03 May04 May05 May06 May07 May10 May11 May17 May18
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.19 0.46 0.45 4.44 4.10

Competitive Comparison of Bioqual's EPS (Diluted)

For the Diagnostics & Research subindustry, Bioqual's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bioqual's PE Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Bioqual's PE Ratio distribution charts can be found below:

* The bar in red indicates where Bioqual's PE Ratio falls into.



Bioqual EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Bioqual's Diluted EPS for the fiscal year that ended in May. 2018 is calculated as

Diluted EPS (A: May. 2018 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(3.662-0)/0.893
=4.10

Bioqual's Diluted EPS for the quarter that ended in May. 2018 is calculated as

Diluted EPS (Q: May. 2018 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(3.662-0)/0.893
=4.10

For stock reported annually, GuruFocus uses latest annual data as the TTM data. EPS (Diluted) for the trailing twelve months (TTM) ended in May. 2018 was $4.10

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bioqual  (OTCPK:BIOQ) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Bioqual EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of Bioqual's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Bioqual (Bioqual) Business Description

Traded in Other Exchanges
N/A
Address
9600 Medical Center Drive, Suite 101, Rockville, MD, USA, 20850
Bioqual Inc is a United States-based medical research company. It is engaged in providing contract research services focused on animal models of human diseases, including AIDS, influenza, RSV infection, flavivirus infections like Zika and Dengue, malaria, hepatitis, and cancer. The company is also involved in the evaluation of vaccines, vaccine therapeutics, microbicides, and drug therapies. It provides services to the federal government, universities, and the life science and pharmaceutical industries. It derives revenue from the provision of contract research services.
Executives
Williams Frank E Jr other: Communication, See Remarks 2789-B HARTLAND ROAD, FALLS CHURCH VA 22043

Bioqual (Bioqual) Headlines

No Headlines